Home Ridge Biotechnologies

Ridge Biotechnologies

In operation
Seed Round Financing
Precision Enzyme and Targeted Drug Developer
Basic
Enterprise Profile

Basic Information

Ridge Biotechnologies is a company that pioneers enzyme and targeted drug design, powering the next wave of precision medicines. Ridge Biotechnologies develops precise enzymes and targeted drug delivery systems aimed at catalyzing the generation of precision medicines. The company offers antibody-drug conjugates, CAR-T therapies, nucleic acid delivery, biocatalysts, radiotherapy, and enzyme-based therapies, enabling drug developers and biotechnology companies to enhance drug stability, manufacturability, and therapeutic outcomes.
Ridge Biotechnologies, Inc.
California,United States of America
15~50 people
January 01, 2024
contact@ridgebio.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Artificial Intelligence Targeted Technology Cell Technology
Application Scenarios
Nuclear Medicine Precision Medicine ADC (Antibody-Drug Conjugate) AI+Pharmaceuticals